PremiumRatingsQuanterix: Buy Rating Maintained Amidst Challenges and Growth Opportunities Quanterix price target lowered to $12 from $15 at Canaccord Quanterix Reports Q1 2025 Results Amid Strategic Advances PremiumPre-EarningsQTRX Upcoming Earnings Report: What to Expect? Quanterix shareholder issues statement on Akoya Biosciences merger pact Quanterix Faces Strategic and Financial Challenges Amid Akoya Acquisition and Market Pressures PremiumThe FlyTikvah intends to vote against Quanterix’s proposed merger with Akoya Quanterix price target lowered to $18 from $28 at Scotiabank Quanterix’s Earnings Call: Growth Amid Challenges